Cargando…
Towards social acceptability of genome-edited plants in industrialised countries? Emerging evidence from Europe, United States, Canada, Australia, New Zealand, and Japan
The agricultural biotechnology world has been divided into two blocks; countries adopting GM crops for commercial cultivation (adopters) and others without any or without relevant cultivation of such crops (non-adopters). Meanwhile, an increasing number of adopter countries have exempted certain gen...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9473316/ https://www.ncbi.nlm.nih.gov/pubmed/36120531 http://dx.doi.org/10.3389/fgeed.2022.899331 |
_version_ | 1784789477533679616 |
---|---|
author | Spök, Armin Sprink, Thorben Allan, Andrew C. Yamaguchi, Tomiko Dayé, Christian |
author_facet | Spök, Armin Sprink, Thorben Allan, Andrew C. Yamaguchi, Tomiko Dayé, Christian |
author_sort | Spök, Armin |
collection | PubMed |
description | The agricultural biotechnology world has been divided into two blocks; countries adopting GM crops for commercial cultivation (adopters) and others without any or without relevant cultivation of such crops (non-adopters). Meanwhile, an increasing number of adopter countries have exempted certain genome-edited (GE) crops from legal GMO pre-market approval and labelling requirements. Among them are major exporters of agricultural commodities such as United States, Canada, and Australia. Due to the relaxed legislation more GE plants are expected to enter the market soon. Many countries in the non-adopter group, however, depend on import of large volumes of agricultural commodities from adopter countries. Unlike first generation GM, certain GE crops cannot be identified as unambiguously originating from genome editing using available techniques. Consequently, pressure is mounting on non-adopter jurisdictions to reconsider their policies and legislations. Against this backdrop, the paper explores recent developments relevant for social acceptability in selected non-adopters, Japan, New Zealand, the EU, Norway, and Switzerland in contrast to United States, Canada, and Australia. While Japan is already opening-up and Norway and Switzerland are discussing revisions of their policies, the EU and New Zealand are struggling with challenges resulting from high court decisions. In an attempt to take a closer look into the inner dynamics of these developments, the concept of social acceptability proposed by Wüstenhagen et al. (Energy Policy, 2007, 35(5), 2683–2691) is employed. This aids the understanding of developments in the jurisdictions considered and identifies specific or cross-cutting challenges. |
format | Online Article Text |
id | pubmed-9473316 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-94733162022-09-15 Towards social acceptability of genome-edited plants in industrialised countries? Emerging evidence from Europe, United States, Canada, Australia, New Zealand, and Japan Spök, Armin Sprink, Thorben Allan, Andrew C. Yamaguchi, Tomiko Dayé, Christian Front Genome Ed Genome Editing The agricultural biotechnology world has been divided into two blocks; countries adopting GM crops for commercial cultivation (adopters) and others without any or without relevant cultivation of such crops (non-adopters). Meanwhile, an increasing number of adopter countries have exempted certain genome-edited (GE) crops from legal GMO pre-market approval and labelling requirements. Among them are major exporters of agricultural commodities such as United States, Canada, and Australia. Due to the relaxed legislation more GE plants are expected to enter the market soon. Many countries in the non-adopter group, however, depend on import of large volumes of agricultural commodities from adopter countries. Unlike first generation GM, certain GE crops cannot be identified as unambiguously originating from genome editing using available techniques. Consequently, pressure is mounting on non-adopter jurisdictions to reconsider their policies and legislations. Against this backdrop, the paper explores recent developments relevant for social acceptability in selected non-adopters, Japan, New Zealand, the EU, Norway, and Switzerland in contrast to United States, Canada, and Australia. While Japan is already opening-up and Norway and Switzerland are discussing revisions of their policies, the EU and New Zealand are struggling with challenges resulting from high court decisions. In an attempt to take a closer look into the inner dynamics of these developments, the concept of social acceptability proposed by Wüstenhagen et al. (Energy Policy, 2007, 35(5), 2683–2691) is employed. This aids the understanding of developments in the jurisdictions considered and identifies specific or cross-cutting challenges. Frontiers Media S.A. 2022-08-31 /pmc/articles/PMC9473316/ /pubmed/36120531 http://dx.doi.org/10.3389/fgeed.2022.899331 Text en Copyright © 2022 Spök, Sprink, Allan, Yamaguchi and Dayé. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Genome Editing Spök, Armin Sprink, Thorben Allan, Andrew C. Yamaguchi, Tomiko Dayé, Christian Towards social acceptability of genome-edited plants in industrialised countries? Emerging evidence from Europe, United States, Canada, Australia, New Zealand, and Japan |
title | Towards social acceptability of genome-edited plants in industrialised countries? Emerging evidence from Europe, United States, Canada, Australia, New Zealand, and Japan |
title_full | Towards social acceptability of genome-edited plants in industrialised countries? Emerging evidence from Europe, United States, Canada, Australia, New Zealand, and Japan |
title_fullStr | Towards social acceptability of genome-edited plants in industrialised countries? Emerging evidence from Europe, United States, Canada, Australia, New Zealand, and Japan |
title_full_unstemmed | Towards social acceptability of genome-edited plants in industrialised countries? Emerging evidence from Europe, United States, Canada, Australia, New Zealand, and Japan |
title_short | Towards social acceptability of genome-edited plants in industrialised countries? Emerging evidence from Europe, United States, Canada, Australia, New Zealand, and Japan |
title_sort | towards social acceptability of genome-edited plants in industrialised countries? emerging evidence from europe, united states, canada, australia, new zealand, and japan |
topic | Genome Editing |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9473316/ https://www.ncbi.nlm.nih.gov/pubmed/36120531 http://dx.doi.org/10.3389/fgeed.2022.899331 |
work_keys_str_mv | AT spokarmin towardssocialacceptabilityofgenomeeditedplantsinindustrialisedcountriesemergingevidencefromeuropeunitedstatescanadaaustralianewzealandandjapan AT sprinkthorben towardssocialacceptabilityofgenomeeditedplantsinindustrialisedcountriesemergingevidencefromeuropeunitedstatescanadaaustralianewzealandandjapan AT allanandrewc towardssocialacceptabilityofgenomeeditedplantsinindustrialisedcountriesemergingevidencefromeuropeunitedstatescanadaaustralianewzealandandjapan AT yamaguchitomiko towardssocialacceptabilityofgenomeeditedplantsinindustrialisedcountriesemergingevidencefromeuropeunitedstatescanadaaustralianewzealandandjapan AT dayechristian towardssocialacceptabilityofgenomeeditedplantsinindustrialisedcountriesemergingevidencefromeuropeunitedstatescanadaaustralianewzealandandjapan |